JasonG.ZittelMD

Geriatrics • Rochester, NY

Physician

Join to view full profile

Dr. Zittel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Zittel's full profile

Already have an account?

Office
601 Elmwood Ave
Rochester, NY 14642
Phone+1 585-275-5823

Fax+1 585-273-1051

Education & Training

University of RochesterFellowship, Geriatric Medicine (Internal Medicine), 2016 - 2017
University of RochesterResidency, Internal Medicine, 2012 - 2015
Pennsylvania State University College of MedicineClass of 2012

Certifications & Licensure

NY State Medical License 2015 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Geriatric Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) Start of enrollment: 2018 Aug 31
Active, not recruiting
Phase 1, Phase 2

Publications & Presentations

PubMed

41 citations
Development of a telehealth geriatric assessment model in response to the COVID-19 pandemic.
Grace DiGiovanni, Kathryn Mousaw, Terri Lloyd, Nancy Dukelow, Bryan Fitzgerald
Journal of Geriatric Oncology. 2020-06-01
45 citations
Association Between Symptom Burden and Physical Function in Older Patients with Cancer
Chintan Pandya, Allison Magnuson, Marie Flannery, Jason Zittel, Paul R. Duberstein
Journal of the American Geriatrics Society. 2019-05-01
61 citations
Older adults with cancer and their caregivers - current landscape and future directions for clinical care
Sindhuja Kadambi, Kah Poh Loh, Richard F. Dunne, Allison Magnuson, Ronald J. Maggiore
Nature Reviews. Clinical Oncology. 2020-09-02

Lectures

A phase II study of enzalutamide (Enz) with dutasteride (Dut) or finasteride (Fin) in men ≥ 65 years with hormone-naive systemic prostate cancer (HNSPCa): Tolerability...
ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019

Press Mentions

Whether You Feel 73 or 37, Age Perception Alone Does Not Spur Treatment DecisionsDecember 19th, 2018
American Society of Clinical Oncology Honors Wilmot Physician with National AwardMay 23rd, 2018
Cancer in Rural Upstate New York: Study Reveals Obstacles, Opportunities for CareFebruary 1st, 2024